The Importance of Hemostasis in Chronic Wound Care: An Open-Label Study Controlled Clinical Study of OMNI-STAT (Chitosan) Versus Standard of Care in Post-Debridement Treatment of Patients with Chronic Wounds with or without Concomitant Use of Anticoagulants by Robert J. Snyder, DPM, MSc, CWS and Brian D. Sigal, DPM, CWS
This article was first published in Wound Care & Hyperbaric Medicine Volume 4 Issue 2. The article is now available to you in downloadable PDF format.
Topics discussed include:
- Epidemiology of Chronic Wounds
- Debridement
- Challenge Associated with the Anticoagulated Patient
- Topical Hemostatic Agents
- The Idea Topical Hemostatic Agent
- Study Design
- Materials and Methods
- Ethical Considerations
- Statistics
- Results
- Trial Endpoints
- Time to Hemostasis
- Secondary Endpoints
- Discussion
- Implications of Findings
- Conclusions
- References
ABOUT THE AUTHORS
Robert J. Snyder, DPM, MSc, CWS
Dr. Robert J. Snyder is a podiatrist with more than 30 years of experience. His practice is limited to wound management and limb preservation. He is a professor and director of clinical research at Barry University’s School of Podiatric Medicine (SPM).
Dr. Snyder is also certified in foot and ankle surgery by the American Board of Podiatric Surgery and is a board-certified wound specialist. He is president of the Association for the Advancement of Wound Care and immediate past-president of the American Board of Wound Management. In addition to his doctorate, Dr. Snyder holds an MSc in Wound Healing and Tissue Science from Cardiff University.
Dr. Snyder has published several book chapters, more than 125 papers on wound care in peer-reviewed and trade journals, and has been a principal investigator on more than 30 randomized controlled trials. He is the medical director for Systagenix and chairman of its Medical Advisory Board.
Brian D. Sigal, DPM, CWS
Dr. Brian D. Sigal has been a podiatrist for 20 years, during which time he has developed an expertise in the practice of wound management and limb salvage.
Dr. Sigal is a diplomat of the American Board of Podiatric Surgery and is certified in foot surgery. Additionally, he holds diplomat status in the American Board of Wound Management and is a certified wound specialist. He is also co-medical director of the Broward Health Coral Springs Center for Wound Care & Hyperbaric Medicine. In addition, Dr. Sigal is currently involved, as sub-investigator, in numerous research studies concerning many innovative wound healing modalities and products.
